267 related articles for article (PubMed ID: 32919422)
1. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.
Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A
J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.
Bagni K; Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Hansen CP; Preus Hasselby J; Holländer NH; Nissen M; Bjerregaard JK; Pfeiffer P; Yilmaz MK; Rasmussen LS; Nielsen SE; Johansen JS
Eur J Cancer Care (Engl); 2020 May; 29(3):e13219. PubMed ID: 31908093
[TBL] [Abstract][Full Text] [Related]
3. Body mass index does not affect the survival of pancreatic cancer patients.
Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Cancer: Multicenter Prospective Data Collection and Analysis by the Hungarian Pancreatic Study Group.
Lakatos G; Balázs A; Kui B; Gódi S; Szücs Á; Szentesi A; Szentkereszty Z; Szmola R; Kelemen D; Papp R; Vincze Á; Czimmer J; Pár G; Bajor J; Szabó I; Izbéki F; Halász A; Leindler L; Farkas G; Takács T; Czakó L; Szepes Z; Hegyi P; Kahán Z
J Gastrointestin Liver Dis; 2016 Jun; 25(2):219-25. PubMed ID: 27308654
[TBL] [Abstract][Full Text] [Related]
5. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.
Chen Q; Ning Z; Wang L; Ying H; Dong S; Zhang C; Shen X; Guo Y; Chen H; Zhu X; Shen Y; Shi W; Hua Y; Wang K; Lin J; Xu L; Chen L; Feng L; Zhang X; Xie J; Sun B; Sun Y; Gu W; Kang M; Tang Z; Chen Z; Chen Z; Liu L; Yu J; Li Z; Meng Z
Oncotarget; 2016 Dec; 7(51):85603-85612. PubMed ID: 27811354
[TBL] [Abstract][Full Text] [Related]
6. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
[TBL] [Abstract][Full Text] [Related]
7. Modifiable and non-modifiable risk factors for pancreatic cancer: A review.
Midha S; Chawla S; Garg PK
Cancer Lett; 2016 Oct; 381(1):269-77. PubMed ID: 27461582
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathologic features of familial pancreatic cancer.
Humphris JL; Johns AL; Simpson SH; Cowley MJ; Pajic M; Chang DK; Nagrial AM; Chin VT; Chantrill LA; Pinese M; Mead RS; Gill AJ; Samra JS; Kench JG; Musgrove EA; Tucker KM; Spigelman AD; Waddell N; Grimmond SM; Biankin AV;
Cancer; 2014 Dec; 120(23):3669-75. PubMed ID: 25313458
[TBL] [Abstract][Full Text] [Related]
10. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
Sheikh M; Masoudi S; Bakhshandeh R; Moayyedkazemi A; Zamani F; Nikfam S; Mansouri M; Shishavan NG; Nikeghbalian S; Brennan P; Malekzadeh R; Pourshams A
PLoS One; 2020; 15(12):e0243511. PubMed ID: 33275621
[TBL] [Abstract][Full Text] [Related]
11. Early onset pancreatic malignancies: Clinical characteristics and survival associations.
Beeghly-Fadiel A; Luu HN; Du L; Shi C; McGavic DP; Parikh AA; Raskin L
Int J Cancer; 2016 Nov; 139(10):2169-77. PubMed ID: 27416564
[TBL] [Abstract][Full Text] [Related]
12. Familial pancreatic cancer.
Rieder H; Bartsch DK
Fam Cancer; 2004; 3(1):69-74. PubMed ID: 15131409
[TBL] [Abstract][Full Text] [Related]
13. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China.
Ben Q; Li Z; Liu C; Cai Q; Yuan Y; Wang K; Xiao L; Gao J; Zhang H
Pancreas; 2012 Apr; 41(3):435-40. PubMed ID: 22422136
[TBL] [Abstract][Full Text] [Related]
16. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
Lee S; Hwang HK; Kang CM; Lee WJ
Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic delay does not influence survival of pancreatic cancer patients.
Stornello C; Archibugi L; Stigliano S; Vanella G; Graglia B; Capalbo C; Nigri G; Capurso G
United European Gastroenterol J; 2020 Feb; 8(1):81-90. PubMed ID: 32213057
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma.
Del Chiaro M; Zerbi A; Falconi M; Bertacca L; Polese M; Sartori N; Boggi U; Casari G; Longoni BM; Salvia R; Caligo MA; Di Carlo V; Pederzoli P; Presciuttini S; Mosca F
Pancreatology; 2007; 7(5-6):459-69. PubMed ID: 17912010
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.
Stotz M; Eisner F; Szkandera J; Absenger G; Kornprat P; Lackner C; Samonigg H; Gerger A; Pichler M
J Clin Pathol; 2013 Sep; 66(9):753-7. PubMed ID: 23750038
[TBL] [Abstract][Full Text] [Related]
20. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]